Half Year 2023 Biocon Ltd Earnings Call Transcript
Good morning, everyone. I'm Saurabh Paliwal from Biocon's Investor Relations team, and I would like to welcome you to this earnings call for the second quarter of fiscal '23. (Operator Instructions) Please note that the chat box in the Zoom application is disabled, but you can raise any technical concerns by sending us an e-mail to [email protected]. Please note that this conference is being recorded. A recording will be made available on our website within a day and the transcript of the call shall be made available subsequently.
Today, to discuss the company's business performance and outlook for the quarter we have Dr. Kiran Mazumdar-Shaw, our Executive Chairperson; Mr. Siddharth Mittal, CEO and MD of Biocon Limited; along with other senior management colleagues across the business segments, including Generics, Biosimilars and Research Services.
Before we begin, I want to remind everyone about the safe harbor related to today's earnings call. Comments made during the call may be forward-looking in nature based on management's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |